跳至主要内容
临床试验/DRKS00000525
DRKS00000525已完成3 期

Pain assessment in advanced dementia. Validity of the German PAINAD (= BESD) - A prospective double-blind randomised placebo-controlled trial - PAINAD II Study

Agaplesion Bethesda Klinik Ulm, Akademisches Krankenhaus der Universität Ulm0 个研究点目标入组 45 人开始时间: 2010年8月24日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 one(—)
性别
All

入选标准

  • Diagnosis of dementia (Alzheimer’s disease, vascular type and combined), non-communicative patients MMSE < 20, PAINAD-G-score = 4 during activities, no analgesic medication or only medication of WHO – Stage I (will be continued unchanged), highly pain-associated diseases (such as arthrosis, chronic back pain), informed consent of the guardian

排除标准

  • Participation in different studies, cancer, other forms of dementia differing from the above, other diseases causing communication impairments (such as apoplexy, Parkinson’s, multiple sclerosis), analgesic medication of WHO – Stage II or III, adverse effect of Oxycodone and contra- indication against Oxycodone according to the instruction leaflet

研究者

发起方
Agaplesion Bethesda Klinik Ulm, Akademisches Krankenhaus der Universität Ulm

相似试验